Björnsson Robert A, Sigurdsson Sigurdur Sölvi, Arnarson Dagur Tjörvi, Logason Egill, Björnsson Einar Stefan
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, The National University Hospital of Iceland, Reykjavik, Iceland.
Drug Saf. 2025 Mar 12. doi: 10.1007/s40264-025-01541-w.
Most epidemiological studies have found antibiotics to be the most common cause of drug-induced liver injury (DILI). It is unclear what the risk of DILI is associated with different antibiotics.
The aim of the study was to assess the frequency of DILI due to the most commonly used antibiotics among inpatients, in a population-based setting.
Patients who were treated with the 14 most-used antibiotics at Landspitali University Hospital Iceland 2012-2023, with concomitant: > 5 × upper limit of normal (ULN) of alanine aminotransferase (ALT) and/or > 2 × ULN of alkaline phosphatase (ALP), were identified. If DILI was a potential cause, the Revised Electronic Causality Assessment Method (RECAM) method was used to determine likelihood of DILI.
Overall 2292 patients fulfilled the inclusion criteria, 52 of whom were found to have DILI, median age 67 (range 21-93) years, 58% females, 17 (33%) with jaundice and three (5.8%) died of liver failure. The most commonly implicated agent was amoxicillin/clavulanate (n = 23) in 1:1327 users (0.075%), ceftriaxone (n = 8) 1:3779 (0.02%), cefazolin (n = 7) 1: 6363 (0.016%), cloxacillin 1:6024 (n = 4) (0.017%), piperacillin/tazobactam (n = 2) 1:1551 (0.097%), vancomycin (n = 2) 1:1966 (0.076%), trimethoprim-sulfamethoxazole (TMP/SMX) (n = 3) 1:1096 (0.091%) and ciprofloxacin (n = 1) 1:10,938 (0.009%). In two cases, more than one antibiotic was considered likely.
Drug-induced liver injury was found to be a rare adverse effect of antibiotics in a population-based setting. Overall, 33% presented with jaundice but three died of liver failure, all due to amoxicillin/clavulanate, which was the most common cause occurring in around 1 in 1300 users. However, TMP/SMX was associated with the highest proportional risk of DILI.
大多数流行病学研究发现抗生素是药物性肝损伤(DILI)最常见的原因。目前尚不清楚不同抗生素导致DILI的风险情况。
本研究旨在评估在基于人群的住院患者中,最常用抗生素所致DILI的发生频率。
确定2012年至2023年在冰岛兰斯皮塔利大学医院接受14种最常用抗生素治疗,同时伴有丙氨酸氨基转移酶(ALT)>5倍正常上限(ULN)和/或碱性磷酸酶(ALP)>2倍ULN的患者。如果DILI是潜在原因,则使用修订后的电子因果关系评估方法(RECAM)来确定DILI的可能性。
共有2292例患者符合纳入标准,其中52例被发现患有DILI,中位年龄67岁(范围21-93岁),女性占58%,17例(33%)出现黄疸,3例(5.8%)死于肝衰竭。最常涉及的药物是阿莫西林/克拉维酸(n = 23),每1327名使用者中有1例(0.075%),头孢曲松(n = 8)每3779名使用者中有1例(0.02%),头孢唑林(n = 7)每6363名使用者中有1例(0.016%),氯唑西林每6024名使用者中有1例(n = 4)(0.017%),哌拉西林/他唑巴坦(n = 2)每1551名使用者中有1例(0.097%),万古霉素(n = 2)每1966名使用者中有1例(0.076%),甲氧苄啶-磺胺甲恶唑(TMP/SMX)(n = 3)每1096名使用者中有1例(0.091%),环丙沙星(n = 1)每10938名使用者中有1例(0.009%)。在2例病例中,不止一种抗生素被认为可能有关。
在基于人群的研究中,发现药物性肝损伤是抗生素罕见的不良反应。总体而言,33%的患者出现黄疸,但3例死于肝衰竭,均由阿莫西林/克拉维酸引起,这是最常见的原因,约每1300名使用者中就有1例。然而,TMP/SMX与DILI的比例风险最高相关。